The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.
The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...
The GLORIOUS trial tested whether intravenous infusion of exenatide could reduce complications during and after cardiac ...